MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/ccm.0000000000001347

Медицинская библиотека · Critical care medicine · 2016

Population Pharmacokinetics of Fentanyl in the Critically Ill.

Choi Leena, Ferrell Benjamin A, Vasilevskis Eduard E, Pandharipande Pratik P, Heltsley Rebecca, Ely E Wesley, Stein C Michael, Girard Timothy D

СтатьяПоддержка NIH: внешняя программаПоддержка правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

To characterize fentanyl population pharmacokinetics in patients with critical illness and identify patient characteristics associated with altered fentanyl concentrations.

DESIGN

Prospective cohort study.

SETTING

Medical and surgical ICUs in a large tertiary care hospital in the United States.

PATIENTS: Patients with acute respiratory failure and/or shock who received fentanyl during the first 5 days of their ICU stay.

MEASUREMENTS AND MAIN

RESULTS

We collected clinical and hourly drug administration data and measured fentanyl concentrations in plasma collected once daily for up to 5 days after enrollment. Among 337 patients, the mean duration of infusion was 58 hours at a median rate of 100 μg/hr. Using a nonlinear mixed-effects model implemented by NONMEM, we found that fentanyl pharmacokinetics were best described by a two-compartment model in which weight, severe liver disease, and congestive heart failure most affected fentanyl concentrations. For a patient population with a mean weight of 92 kg and no history of severe liver disease or congestive heart failure, the final model, which performed well in repeated 10-fold cross-validation, estimated total clearance, intercompartmental clearance (Q), and volumes of distribution for the central (V1) and peripheral compartments (V2) to be 35 L/hr (95% CI, 32-39 L/hr), 55 L/hr (95% CI, 42-68 L/hr), 203 L (95% CI, 140-266 L), and 523 L (95% CI, 428-618 L), respectively. Severity of illness was marginally associated with fentanyl pharmacokinetics but did not improve the model fit after liver and heart diseases were included.

CONCLUSIONS

In this study, fentanyl pharmacokinetics during critical illness were strongly influenced by severe liver disease, congestive heart failure, and weight, factors that should be considered when dosing fentanyl in the ICU. Future studies are needed to determine if data-driven fentanyl dosing algorithms can improve outcomes for ICU patients.

Для цитирования: Choi Leena, Ferrell Benjamin A, Vasilevskis Eduard E, Pandharipande Pratik P, Heltsley Rebecca, Ely E Wesley, Stein C Michael, Girard Timothy D. Population Pharmacokinetics of Fentanyl in the Critically Ill.. Critical care medicine. 2016. DOI: 10.1097/ccm.0000000000001347.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.